(Q30410798)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Sergey A Tarasov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Vladimir V Zarubaev

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Evgeniy A Gorbunov

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Svetlana A Sergeeva

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

8 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

219-224

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: insights into viral virulence, tissue tropism and host pathogenesis.

18 January 2020

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Ultralow doses of anti-idiotypic antibodies to human gamma-interferon: immunotropic properties

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Epidemic viral pneumonia.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Medical management of influenza infection.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Modulation of cytokine production by 7-hydroxycoumarin in vitro and its efficacy against influenza infection in mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Respiratory epithelial cells in innate immunity to influenza virus infection

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Oseltamivir resistance--disabling our influenza defenses

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Interferon status in children during acute respiratory infections. Therapy with interferon

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Anaferon (pediatric formulation) in prophylactics of acute respiratory viral infection in children

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Oseltamivir-resistant 2009-2010 pandemic influenza A (H1N1) in an immunocompromised patient.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Developing new antiviral agents for influenza treatment: what does the future hold?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Antiviral activity of Anaferon (pediatric formulation) in mice infected with pandemic influenza virus A(H1N1/09).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Influenza A strain-dependent pathogenesis in fatal H1N1 and H5N1 subtype infections of mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Study of efficiency of therapeutic and preventive anaferon (pediatric formulation) in mice with influenza infection.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Combination antiviral therapy for respiratory virus infections

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Active NF-kappaB signalling is a prerequisite for influenza virus infection.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ANTIVIRAL.2011.11.018

Identifiers

DOI

10.1016/J.ANTIVIRAL.2011.11.018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178245%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference